• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    DepoMed Inc. (DEPO)

    -NasdaqGS
    20.76 Up 0.51(2.52%) May 22, 4:00PM EDT
    |After Hours : 20.76 0.00 (0.00%) May 22, 4:25PM EDT
    Add to Portfolio
    Prev Close:20.25
    Open:20.41
    Bid:N/A
    Ask:21.50 x 300
    1y Target Est:28.00
    Beta:1.68
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:20.14 - 20.94
    52wk Range:9.85 - 28.16
    Volume:1,425,190
    Avg Vol (3m):1,842,630
    Market Cap:1.24B
    P/E (ttm):10.12
    EPS (ttm):2.05
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DEPOUp 2.52%1.24B
    MRKDown 1.20%167.76B
    PFEDown 0.23%211.08B
    TEVADown 0.60%51.77B

    Key Statistics

    Forward P/E (1 yr):17.74
    P/S (ttm):3.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.27
    Quarterly EPS Est (Jun-15) :0.01
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.50

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the management of postherpetic neuralgia; CAM... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback